美国药品NDC（国家药品编码）与药品说明书数据库（U.S. FDA National Drug Code DataBase）

NDC包装代码	产品NDC	产品类型	商品名	通用名	剂型	给药途径	上市日期	结束日期	市场类别	申请号	标签持有者	活性成分	规格	包装描述
51754-1200-3	51754-1200	HUMAN PRESCRIPTION DRUG	Bloxiverz	Neostigmine Methylsulfate	INJECTION	INTRAVENOUS	20231231	N/A	NDA	NDA204078	Exela Pharma Sciences, LLC	NEOSTIGMINE METHYLSULFATE	1 mg/mL	10 SYRINGE, PLASTIC in 1 CARTON (51754-1200-3) / 5 mL in 1 SYRINGE, PLASTIC
51754-1210-3	51754-1210	HUMAN PRESCRIPTION DRUG	Bloxiverz	Neostigmine Methylsulfate	INJECTION	INTRAVENOUS	20130724	N/A	NDA	NDA204078	Exela Pharma Sciences, LLC	NEOSTIGMINE METHYLSULFATE	.5 mg/mL	10 CARTON in 1 PACKAGE (51754-1210-3) / 1 VIAL, MULTI-DOSE in 1 CARTON (51754-1210-1) / 10 mL in 1 VIAL, MULTI-DOSE
51754-1220-3	51754-1220	HUMAN PRESCRIPTION DRUG	Bloxiverz	Neostigmine Methylsulfate	INJECTION	INTRAVENOUS	20130724	N/A	NDA	NDA204078	Exela Pharma Sciences, LLC	NEOSTIGMINE METHYLSULFATE	1 mg/mL	10 CARTON in 1 PACKAGE (51754-1220-3) / 1 VIAL, MULTI-DOSE in 1 CARTON / 10 mL in 1 VIAL, MULTI-DOSE
51754-1240-3	51754-1240	HUMAN PRESCRIPTION DRUG	Bloxiverz	neostigmine methylsulfate	INJECTION	INTRAVENOUS	20210303	N/A	NDA	NDA204078	Exela Pharma Sciences, LLC	NEOSTIGMINE METHYLSULFATE	1 mg/mL	10 CARTON in 1 PACKAGE (51754-1240-3) / 1 VIAL, MULTI-DOSE in 1 CARTON / 10 mL in 1 VIAL, MULTI-DOSE
51754-1240-1	51754-1240	HUMAN PRESCRIPTION DRUG	Bloxiverz	neostigmine methylsulfate	INJECTION	INTRAVENOUS	20210303	N/A	NDA	NDA204078	Exela Pharma Sciences, LLC	NEOSTIGMINE METHYLSULFATE	1 mg/mL	1 VIAL, MULTI-DOSE in 1 CARTON (51754-1240-1) / 10 mL in 1 VIAL, MULTI-DOSE